Retatrutide Reta 10mg Lyophilized Powder ( Research Use Only)

Description

Retatrutide 10mg Lyophilized Powder

(Mixing Solution Sold Separately)
Also Known as RETA

Product Description:

Retatrutide is a research-grade GGG tri-agonist peptide that targets GLP-1, GIP, and glucagon receptors. Unlike standard GLP-1 agonists, Retatrutide uniquely activates the glucagon receptor, offering versatility for metabolic research. Its activation of the glucagon receptor is studied for its potential to increase glucagon production, supporting research focused on fat metabolism and basal metabolic rate. Additionally, Retatrutide’s effects on GLP-1 and GIP receptors are researched for their potential roles in delayed gastric emptying and appetite regulation, making it a valuable research tool for studies on obesity and metabolic health.

Properties:

• CAS Number: 2381089
• PubChem CID: 474492235
• Molecular Weight: ~4845.444 g/mol
• Molecular Formula: C223H343F3N46O70

Research Applications:

Retatrutide is used in various preclinical research models to explore:

• Fat Metabolism and Energy Expenditure:
  Research investigates the role of glucagon receptor activation in fat breakdown and energy utilization in metabolic studies.
• Appetite Control:
  Studies focus on the interactions between GLP-1 and GIP receptors and their potential role in regulating appetite and gastric emptying.
• Obesity and Metabolic Disorders:
  Retatrutide is used as a comprehensive tool in the study of obesity-related metabolic pathways and disorders involving energy regulation.

Important Disclaimer:

This product is strictly intended for research purposes only and is not for human or veterinary use. It is not intended for therapeutic or diagnostic applications. All research involving this product must be conducted in accordance with local regulations and institutional guidelines.